ISEC: a program to calculate insulin secretion
- PMID: 8894385
- DOI: 10.1016/0169-2607(96)01755-5
ISEC: a program to calculate insulin secretion
Abstract
ISEC (Insulin SECretion) is a computer program which calculates pre-hepatic insulin secretion from plasma C-peptide measurements. The program uses a regression (population) model to derive parameters of C-peptide kinetics from subject's gender, type (normal, obese, non-insulin dependent diabetes mellitus), age, weight, and height. Insulin secretion is calculated as a piece-wise constant (step) function with flexible step length allowing for a fine resolution of the secretion profile between measurements. A constrained regularisation method of deconvolution is employed to carry out the calculations. The calculated profile satisfies three properties: (i) it fits the measurement within the given level of the measurement error, (ii) it is non-negative, and (iii) it has a minimum value of a regularisation criterion (norm of second differences) which quantifies the degree of deviation of the secretion profile from a straight line. Both theoretical aspects and specific features related to ISEC are considered. To exemplify the use of ISEC, pre-hepatic insulin secretion is calculated during meal tolerance test, frequently sampled intravenous glucose tolerance test, hyperinsulinaemic euglycaemic glucose clamp, and basal conditions with frequent sampling.
Similar articles
-
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.Diabetologia. 2001 Oct;44(10):1339-48. doi: 10.1007/s001250100639. Diabetologia. 2001. PMID: 11692185
-
Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule.Diabetologia. 1998 May;41(5):548-54. doi: 10.1007/s001250050945. Diabetologia. 1998. PMID: 9628272
-
A numerical deconvolution method to estimate C-peptide secretion in humans after an intravenous glucose tolerance test.Metabolism. 2009 Jul;58(7):891-900. doi: 10.1016/j.metabol.2009.03.003. Metabolism. 2009. PMID: 19394979
-
Levels of the first-phase insulin secretion deficiency as a predictor for type 2 diabetes onset by using clinical-metabolic models.Ann Saudi Med. 2015 Mar-Apr;35(2):138-45. doi: 10.5144/0256-4947.2015.138. Ann Saudi Med. 2015. PMID: 26336020 Free PMC article.
-
How to measure insulin secretion.Diabetes Metab Rev. 1994 Jul;10(2):91-117. doi: 10.1002/dmr.5610100204. Diabetes Metab Rev. 1994. PMID: 7956679 Review. No abstract available.
Cited by
-
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition.Diabetes. 2020 Dec;69(12):2619-2629. doi: 10.2337/db20-0369. Epub 2020 Oct 1. Diabetes. 2020. PMID: 33004472 Free PMC article.
-
Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.Front Nutr. 2022 Apr 29;9:889710. doi: 10.3389/fnut.2022.889710. eCollection 2022. Front Nutr. 2022. PMID: 35571890 Free PMC article.
-
Prediction of metabolic subphenotypes of type 2 diabetes via continuous glucose monitoring and machine learning.Nat Biomed Eng. 2025 Aug;9(8):1222-1239. doi: 10.1038/s41551-024-01311-6. Epub 2024 Dec 23. Nat Biomed Eng. 2025. PMID: 39715896 Free PMC article.
-
Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.Front Nutr. 2022 Aug 19;9:933118. doi: 10.3389/fnut.2022.933118. eCollection 2022. Front Nutr. 2022. PMID: 36061897 Free PMC article.
-
Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects.Nutrients. 2018 Sep 12;10(9):1285. doi: 10.3390/nu10091285. Nutrients. 2018. PMID: 30213037 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical